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ABSTRACT
This paper attempts to review the various antidotes available for countering cyanide threat in
the light of the toxicity associatcd with it. It also critically evaluates the drawbacks and advantages
of these antidotes for their thcrapcutic and/or prophylactic utility. The physico-chemical properties
of hydrogen cyanide which make it a chemical warfare agent have also been highlighted. In an attempt
to make the complex chemical and biological processes understandable, the chemical structures of
the antidotes have been included ~nd simple mechanistic pathways have been used to show the role
of antidotes in activating the inhibited enzymes.
.INTRODUCTION
Hydrogen cyanide, discovered by a Swedish chemist
C.W. Scheele in 1782, has been recognised as one of
the most rapid poisons. Cyanide toxicity has long been
a problem in livestock grazing range containing
cyanogenic plantsl. The toxicity of these plants is
associated with specific glycosides which contain a
cyanide moiety. The worldwide industrial development
has become a major threat so far as cyanide is
concerned. Cyanogenic materials are produced in
electroplating, steel, aluminium, paints and
petrochemical industries2. The major problem,
however, comes from the intentional ingestion of
cyanide for suicidal and homicidal purposes. The high
toxicity associated with hydrogen cyanide (HCN) has
made it a useful chemical warfare (CW) a~ent. The
French were the first to use it in 'the Battle of Somme
in July 1916 and since then it has been used as a CW
agent. A very recent example of its use is by Iraq in
her cQnflict with Iran.
coloured HCN is considered to be less dangerous
because it is in the process of alteration. In the gaseous
state it is colourless with a vapour density lower than
air. Some of the salient physico-chemical properties of
HCN have been listed in Table I.
Because of its high vapour pressure' and low density
it is difficult to maintain a high concentration of HCN
in an open place. To make it more persistent, numerous
Table I. Physico-chemical properties of hydrogen cyanide
Molecularwpioht
Boiling point
Freezing point
Vapourdensity
Specific gravity
27
26.5°C
-13.4°C
0.948
0.7058 (7 OC)
0.6969 ( 18 OC)
138.5 C
53.5atm
210.7 caVg
873,{XX) mg/mJ
Critical temperature
Critical pressure
Heat of vaporisation
Volatility at 20 oC
Solubility at 20°C
(a) Organic solvents
2. PHYSICO-CHEMICAL PROPERTIES
The physico-chemical properties of HCN make it a
useful CW agent. Pure anhydrous HCN is a colourless
liquid with a peculiar odour of bitter almond. The
Alcohol, ether, glycerol,
chlorofonn, benzene.
Dissolves to give acidic solution.(b) Water
--~
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artifices have been used during the war. HCN is miscible
in all proportions with alcohol, ether, glycerol,
chloroform, benzene, etc. It dissolves in water to fonD
a weak acidic solution. Even in the anhydrous
conditions, HCN cannot be kept for long as it gradually
decomposes, occasionally with explosive force. The
decomposition may be prevented or retarded by the
addition of small amounts of mineral acids.
A
Table 2. Lethal concentrations or cyanide
Acute toxicity by intravenous (iv.). intramuscular (i.m.) and
intraperitoneal (i.p.) routes
Species. Sex Compound Route LD~ in mg/kg
(95% confidence limits)
HCN
HCN
HCN
NaCN
NaCN
NaCN
KCN
KCN
KCN
HCN
HCN
HCN
0.59 (0.55-0.65)
0.95(0.81-1.11)
1.95 (1.~>-2.(X)
1.23(1.11-1.34)
1.67(1.51-1.84)
2.79(2.48-3.09)
1.89(1.66-2.13)
3.27 (2.70-4.08)
3.99(3.40-4.60)
2.80(2.70-2.90)
2.23(1.93-2.59)
2.64 (2.38-2.96)
Rabbit, F I. v.
i.m.
i.p.
i.v.
i.m.
i.p.
i.v.
I.m.
i.p.
i.p.
i.p.
i.p.
Mouse,F
Rat,F
Guinea Pig, F
B. Acute inhalation toxicity for HCN vapour
Exposure TimeSpecies, Sex
3. cy ANIDE INTOXICA nON
The toxic effect of cyanide is attributed to a decrease
in the tissue utilisation of oxygen due to inhibition of
cytochrome oxidase3-5, an enzyme which occupies a
critical position in cellular metabolism. The cyanide
poisoning very frequently is a massive poisoning, where
the amount of cyanide greatly exceeds the concentration
necessary to inhibit cytochrome oxidase. In such
intoxication many other enzymes and biological systems
are also inhibited6. Cyanide toxicity "may therefore be
considered as a complex effect on various enzyme
systems. The lethality of cyanide may be judged from
the values7 given in Table 2.
The mechanism of cyanide inhibition of cytochrome
oxidase is a complicated process and has been studied
extensively8-IO. The binding of cytochrome oxidase, a
multimeric iron enzyme complex, with cyanide has been
found to involve a two-step reaction. The first step is
the penetration of cyanide into a protein crevice, with
initial binding of cyanide to protein while the second
step is the binding of cyanide to heme iron 10. Though
the cytochrome oxidase-cyanide complex is quite stable,
in the presence of reducing equivalents, cyanide cali
readily dissociate from the complex, reactivating the
cytochrome oxidase6. From the structure of cytochrome
oxidase and other enzymes inhibited by cyanide, it has
been demonstrated that the basis for the inhibiting
properties may be attributed to its ability to complex
with metals. Another mechanism for cyanide inhibition
of certain enzymes involves a chemical reaction between
cyanide and a Schiff base intermediate, forming
cyanohydrin! !.!2.
Median Lethal Toxicity as
LC.10 in mg/m]
(95% confidence limits)
---
Rabbit, F 2432(2304-2532)
409 (321-458)
208 (154-276)
1129 (664-1471)
493 (372-661)
173 (159-193)
Rat.F
depending on the dose, cramps with opisthotonos and
finally respiratory arrest. After inhalation, oral or
percutaneous absorption of cyanide, the cell respiration
is inhibited and the oxygen, therefore, cannot react with
the hydrogen to form water in the cells and remains in
the venous blood. This is why people poisoned with
cyanide exhibit red face and red skin which is one of
the most apparent symptoms of cyanide poisoning. The
concentration of hydrogen emerging from the metabolic
pathways causes an acidosis in the celll4.
In the pharmacokinetic studies on cyanide poisoning
with 14C-Iabelled cyanide, the concentration of cyanide
in the blood increased relatively slowly as compared to
the plasma, where the concentration reached 40 JlM/ml
in 3 min. This concentration is sufficient for the
4. SYMPTOMS OF CY ANIDE INTOXICATION
One of the first symptoms of cyanide poisoning is a
deep and rapid hyperventilation caused by stimulation
of the carotid sinus13. Cyanide in low concentrations
causes headache, nausea and vomiting and then,
n1
45s
5min
35min
1 min
5min
3Omin
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respiratory arrest. If, however, the concentration of
cyanide in plasma falls below this level, respiration
occurs spontaneously without any artificial respiration.
On the other hand, if the concentration of cyanide in
plasma reached 70p. M/ml, the heart beat ceases about
5 min after the respiratory arrestl5.
s. ESSENTIALS OF DIAGNOSIS
Cyanide poisoning is notoriously difficult to
diagnose without a history of exposure 16-11. The
presence of an odour of oil 'of bitter almond in
respiration and the appearance of red face and skin are
the most apparent diagnostic symptoms. The final
diagnosis for the oral consumption of cyanide comes by
performing the Lee Jones test in gastric aspirate, the
green-blue colouration of ferricyanide confirms the
presence of cyanidel8.
ACTION MECHANISMS OF TREA TMENT
APPROACHES
6.
Once diagnosed, a variety of approaches have been
proposed for the treatment of cyanide poisoning. These
approaches may be classified under three main heads
depending upon their mechanisms of action.
cyanmethaemoglobin is formed restoring the
cytochrome oxidasel9 (Scheme I).
The chemical structures of various cyanide
antidotes are shown in Fig. I. Amyl nitrite (I) was the
first methaemoglobin former to be employed for
antagonising cyanide intoxication2o, and sodium nitrite
(11) was used21 subsequently. The efficacy of amyl nitrite
in cyanide treatment, however, has been since
questioned22. The main limitation of using the nitrites
in cyanide intoxication. was the relatively slow rate of
methaemoglobin formation23.24. The respiratory arrest
and inhibition of cellular oxidation by cyanide, however ,
calls for a quick action of the antidotes. Subsequently,
a series of investigations24-26 led to the development of
4-dimethylaminophenol (DMAP) (111) as the agent of
choice because of its rapid methaemoglobin formation.
DMAP has since proved its superiority as an antidote
in cyanide poisoning in dogs and humans26.27. DMAP
is most effective after intravenous (i. v. ) injection and
forms substantial amount of methaemoglobin in < I
min, thereby trapping cyanide within red cellsI5.2R.
Additionally, DMAP administered in the absence of
cyanide produces no ill effects other than an unwanted
methaemoglobinemia. It is because of this methaemo-
globinemia that some workers have doubted its efficacy
as a cyanide antidote29. Most of the workers have,
however, accepted the superiority of DMAP as a
therapeutic and prophylactic agent against cyanide
poisoning26.27.
6.1 Methaemoglobin Formers
The main objective in the treatment of cyanide
poisoning by methaemoglobin formers is to produce a
high concentration of methaemoglobin (Hb-Fe3+).
Methaemoglobin competes with cytochrome oxidase
(Cytox-Fe3+) for cyanide ion. The concentration
gradient favours methaemoglobin and
Some workers still indicate the efficacy of sodium
nitrite Qver other methaemoglobin fonners and relate
its superiority to the more prolonged
Hb Fe2+ Hb Fe3+MF
( HAEMOGLOBIN ) ( METHAEMOGlOBIN
FORMER)
( METHAEMOGLOBIN )
Hb Fe.3+ Hb Fe3+ CN Fe3.
I
Cyt Ox
CN
I
Fe3.
I
Cyt Ox
( INACTIVE ) (ACTIVE)( cy ANMETHAEMOGLOBIN )
MechanIsm of detoxification with methaemoglobln formers.Scheme I
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6.2 Cyanohydrin Formers
The second approach utilised in countering cyanide
threat is based on the fact that cyanide being a
nucleophile can interact readily with a carbonyl function
resulting in the-formationof cyanohydrin37 (Scheme 2).
Sodium pyruvate (VI in Fig.l) was the first
compound reported in this class to antagonise the lethal
effects of cyanide in mice38. Sodium pyruvate has many
theoretical advantages over the conventional cyanide
antagonist, i.e. , sodium nitrite. Its direct reaction with
cyanide and its ability to distribute to the sites of cyanide
localisation39 makes it a good cyanide antagonist.
Another compound of this family which has been
explored is a- ketoglutaric acid (a-KG) (VII in Fig. I).
This compound has been reported to be as effective as
sodium nitrite and sodium thiosulphate in mice40. A
detailed study on the mechanism of binding of a- KG
to cyanide clearly revealed that the antagonising effect
is due to the cyanohydrin formation which was
confirmed by l!V, GC and HPLC studies41. Further,
its efficacy as cyanide antidote has been assessed by its
ability to antagonise cyanide-induced inhibition of brain
cytochrome oxidase41.
There is only one report on the use of
pyridoxal-5'-phosphate (PLP) (VIII in Fig. 1) for
antagonising cyanide-induced toxicity42. PLP, the active
co-factor from vitamin B6, readily forms covalent
complexe~ with cyanide, resulting in the formation of
cyanohydrin and thereby prolonging the survival time
dramaticaUy. This extension of survival time in a human
patient, would allow time to initiate supportive therapy,
such as respiratory support~ i. v. fluids and hemo- or
peritonial dialysis42.
methaemoglobinemia30.31. The mechanism fer the
enhanced protection of sodium nitrite over other
methaemoglobin formers is that, in the more rapid
methaemoglobin formers, the animals were able to
survive the initial acute cyanide challenge; however ,
they subsequently succumbed to the cyanide released
from the cyanmethaemoglobin pool: A protracted
methaemoglobinemia is therefore presumed to offer
sustained protection against cyanide poisoning. Hence,
the efficacy of sustained methaemoglobinemia was
studied as a result of co-administration of sodium nitrite
(a slow ~ethaemoglobin former)and DMAP (a rapid
methaemoglobin former) in the ratio of 1:3. This
regimen resulted in a persistent methaemoglobinemia
with a corresponding sustained protection against
cyanide over a prolonged period32. Moreover, in vitro
results showed a prolonged persistence of
methaemoglobinemia at higher levels in human
erythrocytes as col:npared with those of the fats because
of the low activity of methae~oglobin reductase in
humans33. It may therefore be speculated that a more
judicious dose of DMAP in combination with sodium
nitrite be envisaged to offer a substantial prophylaxis
against cyanide poisoning in humans.
The toxicity of DMAP is yet another factor which
limits its clinical applications34. The co-administration
of sodium nitrite with DMAP, however, takes care of
the problems associated with the toxicity ofDMAP also,
as the regimen contains a very small amount of it which
is just sufficient to counter the initial threat of cyanide
poisoning.
Besides the nitrites and DMAP, other
met haemoglobin formers are used in limited cases are
p-aminopropiophenone (P APP) (IV) and
hydroxylamine (HA) (V in Fig. 1)35.36.
~( = 0+
CN
I
Fe3+
I
Cyt Ox
Fe3+
I
Cyt Ox
( ACTIVE )(INACTIVE)
( CY ANOHYDRIN )
Mecbanlsm of detoxification with cyanobydrin rormen.Scheme 2.
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Hydroxycobalamine detoxifies cyanide by giving up
its hydroxyl group and binding a cyanyl group, forming
cyanocobalamine (Scheme 4) which is excreted in the
urine45. The cobalt compounds have a greater affinity
for cyanide than cytochrome oxidase and thus free the
enzyme to resume its role in cellular resplration54.
Co2EDT A can cause hypertension, cardiac
arrhythmia and 'ardiac insufficiency if administered in
the absence of cyanide poisoning. It is perhaps in this
context that some workers have recommended the use
of Co2EDT A for comatose patients who do not recover
with classical therapy and for patients lapsing into
unconsciousness despite treatment51.
6.3 Cobalt Compounds
Cobalt ion is known to form a stable complex with
cyanide and has been used in the treatment of cyanide
poisoning43.44, but its use could not receive general
support mainly because of the toxicity of cobalt ions.
However, since the discovery of the antidotal effects of
hydroxycobalamine (IX in Fig. i) in experimental
cyanide poisoning45, the interest in such compounds has
been revived and has led to the testing of many salts
and chelates of cobalt as antidotes to cyanide46-50. Of
these, dicobaltethylenediaminetetracetic acid
(Co2EDTA) (X in Fig. 1) was found to be a more
effective antidote than sodium nitrite51. This led to the
use of Co2 EDT A as the main compound in antidotal
therapy for cyanide poisoning in many European
countries. The selection of Co2EDT A as the preferred
cobalt compound is reasonable, since it was hoped that
many of the toxic effects of cobalt ion would be
minimised by administering its compoWlds as chelates.
It is generally assumed that most cobalt compounds
react directly with free cyanide ion to trap it as a stable
water soluble chelate or as an insoluble precipitate.
Some cobalt compounds, however, may have a
concdmitant effect, namely, methaemoglobin
formation. Cobaltous chloride, for example, is said ~o
generate methaemoglobin in human blood by virtue of
its ability to inhibit the methaemoglobin reductase
activity52.
Sodium cobaltinitrite (XI in Fig. 1) generates
methaemoglobin through release of nitrite ions and it
has therefore been suggested that the entire effect of
cobaltinitrite is due to the methaemoglobin formation48.
Others, however, insist that protectjon against cyanide
induced by cobaltinitrite is more persistent than that by
sodium nitrite because the cobalt moiety acts to prolong
the methaemoglobinemia53. It has however, been
proved that the mechanism of action of Co2EDTA is
by chelation to form cobalticyanide '(Scheme 3).
CN
7. DETOXIFICATION OF CY ANIDE: ROLE OF
SULPHUR DONORS
Sulphur donors have been employed alol}e or in
combination with the above discussed antidotes to
finally detoxify the cyanide and excrete it as thiocyanate.
A variety of sulpllui donors have been used to achieve
this goal55. Of these, sodium thiosulphate (XII in Fig.
1) has been the drug of choice since a long time56.
The mechanism by which thiosulphate detoxifies
cyanide to thiocyanate has been proposed to involve an
enzyme called rhodanase which is present in liver .
Rhodanase is ideal from a toxicological viewpoint since
the enzyme is present in large amounts57, has a high
turnover and catalyses the reaction of cyanide to form
thiocyanate which is essentially irreversible57.58. The
role of rhodanase and the mechanism of its action have
been inve-stigated by using crystalline rhodanase i v. in
combination with sulphur donors to antagonise
cyanide59. .
The reaction mechanism for rhodanase was
developed from the fact that rhodanase is inhibited by
cyanide in the absence of thiosulphate which "makes the
assumption of a primary enzyme-cyanide complex. The
inhibition data indicated that rhodanase contained an
I
Fe3+
I
Cyt Ox
Fe3+
I
,
Cyt Ox
(o2EDTA (0 ((N)2 ++
(COBAL TICYANIDE) ( ACTIVE )( INACTIVE )
Scheme 3. MechanIsm or detoxification with CO1 EDT A.
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CN
I
Fe3+
I
OH
I
tN
I
~e3 + + / Co """ / Co \ + Cyt Ox
Cyt Ox COBALAMINE COBALAMINE
(INACTIVE) (HYDROXYCOBALAMINE} (CYANOCOBALAMINE} (ACTIVE}
Scheme 4. Mechanism or detoxification with hydroxycobalamine.
active disulphide group and it was therefore assumed demonstrated that although oxygen alone gives only
that thiosulphate reacts with the enzyme through this min(jr protection as compared to the classical antidotes,
group, leading to the formation of a sulphenyl it increases the protection when administered in
thiosulphate. This compound then decomposes in the combination with the antidotes63. This protective effect
presence of cyanide to give a sulphenyl thiocyanate of oxygen was observed not only prophylactically63.64
which then rearranges to liberate thiocyanate and but also therapeutically, after the signs and symptoms
regenerates either the enzyme or sulphenyJ thiosulphate of cyanide poisoning were fully manifested63.
complex (Scheme 5).
During the last two decades, attempts have b~en 9. PROTOCOL FOR TREA TMENT
made to get a better understanding about the enzymic
mechanism of sulphur transferases and their role in
cyanide detoxificationN'-h2. These studies implicate a
serum albumin sulphane carrier complex as playing a
major role in cyanide detoxification mechanism.
The presence of a large variety of cyanide antidotes
makes it very difficult to get unanimity as to which is
the more effective regimen. This is so because different
experimental conditions and species of animals have
been employed in testing the efficacy of different
antidotes. The design of studies to assess the efficacy
of antidotes presents several problems other than the
choice of animal model. These relate to the dose of
toxicant, the dose of antidote and the time relation
8. ROLE OF OXYGEN THERAPY IN CY ANIDE
POISONING
The role of oxygen therapy in cyanide poisoning has
long been a debatable point. It is, however, well
s
I
s
$ -$203-
CNs 0 2-
2 3
ENZYME '~NZYME+
s-
(RHODANASE) (SULPHUR DONOR)
s
I
s
SCNENZYME +
s
ENZYME
s-
S-S2 03
ENZYME sc"' -+
s
Scheme s. Mechanism or detoxification with sulphur donors in the presence or rhodanase enzyme.
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between them. While the United States of America
remains faithful to the combination of sodium nitrite
and sodium thiosulphate (Lilly's Cyanide Antidote Kit)
in the treatment of cyanide poisoning, some European
countries, such as Germany use DMAP, whereas others
such as UK and France favour Co2EDTA.The Lilly's
Kit available in the USA is not without inherent
limitations. The toxicity of sodium nitrite and its slow
formation of methaemoglobin are the two main factors
which have always been advocated against this regimen.
It should be possible to make a rational choice between
DMAP and Co2EDTA by comparing their efficacies
against experimental poisoning in animals and by
comparing their relative toxicities. In fact, not many
such comparisons have been carrie.d out. There is only
one reporf7 which showed better survival with DMAP
than with Co2EDT A. A recent report employing the
co-administration of sodium nitrite and DMAP se:ems
to be encouraging as it not only redqces the toxicity of
these chemicals due to reduced dosage but also gives
sustained protection against cyanide threat which is
further augmented by sodium thiosulphate32.
7.
8.
9.
10.
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